Patents : |  |
| US Patent No. | Title |
| 7576209 | Inhibitors of Akt activity
|
| 7588760 | Antagonists specific for denatured collagen and methods of using same
|
| 7588898 | Biomarker for gestational trophoblastic disease
|
| 7589057 | Oil-in-water method for making alpha-2 agonist polymeric drug delivery systems
|
| 7589068 | Inhibitors of Akt activity
|
| 7589098 | Methods and compositions utilizing quinazolinones
|
| 7589118 | IAP BIR domain binding compounds
|
| 7592008 | Membrane scaffold proteins
|
| 7592010 | Albumin fusion proteins
|
| 7595038 | Methods of treatment using antibodies to follistatin-3
|
| 7595047 | Compositions and methods for promoting or inhibiting angiogenesis
|
| 7585895 | Therapeutic substituted cyclopentanes
|
| 7585841 | Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src
|
| 7585647 | Nucleic acid encoding recombinant interferon
|
| 7579166 | Glycoprotein and process for producing the same
|
| 7579320 | IAP BIR domain binding compounds
|
| 7579355 | Inhibitors of Akt activity
|
| 7579473 | c-Met modulators and methods of use
|
| 7582441 | Methods and compositions for treating and diagnosing disease
|
| 7582662 | Body weight gain inhibitor
|
| 7582668 | Imidazoyl-benzamide anti-cancer agents
|
| 7582726 | VEGF receptor antagonists
|
| 7582756 | 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors
|
| 7585622 | Increasing the proliferative capacity of cells using telomerase reverse transcriptase
|
| 7595051 | Methods of treating neovascular glaucoma, macular degeneration and capillary proliferation with alphavbeta3-specific antibodies
|
| 7595325 | Substituted pyrrolo[2,3-d]pyrimidine derivatives useful in cancer treatment
|
| 7608739 | Mitotic kinesin inhibitors
|
| 7611704 | Compositions and methods for treating viral infections using antibodies and immunoconjugates to aminophospholipids
|
| 7611715 | Agaricus extract for preventing the induction or metastasis of cancer
|
| 7611879 | 27877, 18080, 14081, 32140, 50352, 16658, 14223, 16002, 50566, 65552 and 65577 molecules and uses therefor
|
| 7612080 | GTPase inhibitors and use thereof for controlling platelet hyperactivity
|
| 7612182 | Anti-IL-6 antibodies, compositions, methods and uses
|
| 7615223 | Selected immunoconjugates for binding to aminophospholipids
|
| 7615565 | VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines
|
| 7618971 | Mitotic kinesin inhibitors
|
| 7618981 | Imidazopyridinyl-benzamide anti-cancer agents
|
| 7608643 | Compounds for inhibiting KSP kinesin activity
|
| 7608638 | Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
|
| 7608635 | Pyrazole compounds that modulate HSP90 activity
|
| 7595337 | Mitotic kinesin inhibitors
|
| 7597886 | Tumor necrosis factor-gamma
|
| 7598283 | Indazole, benzisoxazole, and benzisothiazole kinase inhibitors
|
| 7598348 | Adiponectin receptor variant, AdipoR2v2
|
| 7598383 | Heterocyclic inhibitors of MEK and methods of use thereof
|
| 7601694 | CLK-peptide and SLK-peptide
|
| 7601716 | Pyridopyrazines and derivatives thereof as ALK and c-Met inhibitors
|
| 7605235 | Anti-tissue factor antibodies and compositions
|
| 7605266 | Azaindole inhibitors of Aurora kinases
|
| 7608394 | Methods and compositions for phenotype identification based on nucleic acid methylation
|
| 7620147 | Orthovoltage radiotherapy
|
